![Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine](https://i1.rgstatic.net/ii/profile.image/272263815626776-1441924160343_Q512/Ioannis-Grivas.jpg)
Ioannis GRIVAS | Professor (Assistant) | DVM, PhD | Aristotle University of Thessaloniki, Thessaloníki | AUTH | Faculty of Veterinary Medicine
![Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering](https://i1.rgstatic.net/ii/profile.image/272261684920337-1441923652186_Q512/Kostas-Spyrou-3.jpg)
Kostas SPYROU | Professor | PhD | National Technical University of Athens, Athens | NTUA | School of Naval Architecture and Marine Engineering
![Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 - Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -](https://onlinelibrary.wiley.com/cms/asset/0dae3851-9a23-473d-bbb9-6a86aa4a983b/bjd.2015.172.issue-5.cover.jpg)
Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -
![Ουσιαστικές οι προτάσεις του Δρα Σπύρου Μεζίτη στην Διακομματική για τον Απόδημο Ελληνισμό - Anamniseis Ουσιαστικές οι προτάσεις του Δρα Σπύρου Μεζίτη στην Διακομματική για τον Απόδημο Ελληνισμό - Anamniseis](https://www.anamniseis.net/wp-content/uploads/2019/05/Symposio-Papanikolaou-Manolas_Mezitis-1024x768.jpg)
Ουσιαστικές οι προτάσεις του Δρα Σπύρου Μεζίτη στην Διακομματική για τον Απόδημο Ελληνισμό - Anamniseis
![Ioannis CHELIOTIS | PostDoc Position | Physicist-Meteorologist (BSc, MSc, PhD) | Laboratoire des Sciences du Climat et l'Environnement, Gif-sur-Yvette | LSCE | Department of Transfers and Tracers in the Environment Ioannis CHELIOTIS | PostDoc Position | Physicist-Meteorologist (BSc, MSc, PhD) | Laboratoire des Sciences du Climat et l'Environnement, Gif-sur-Yvette | LSCE | Department of Transfers and Tracers in the Environment](https://i1.rgstatic.net/ii/profile.image/1065747837104128-1631105493076_Q512/Ioannis-Cheliotis.jpg)
Ioannis CHELIOTIS | PostDoc Position | Physicist-Meteorologist (BSc, MSc, PhD) | Laboratoire des Sciences du Climat et l'Environnement, Gif-sur-Yvette | LSCE | Department of Transfers and Tracers in the Environment
![Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel](https://i.pinimg.com/originals/b9/fd/a9/b9fda93ec37328ca7090c095e52592dd.jpg)
Spyrou Philoxenia Introduces Skopelos to Serbian Travel Agents, Journalists | GTP Headlines | Travel agent, Skopelos, Travel
![A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7249998/bin/medi-99-e20048-g001.jpg)
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis. - Abstract - Europe PMC
![Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 - Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -](https://onlinelibrary.wiley.com/cms/asset/1b64e26e-70d7-4306-bdac-52136782c88f/bjd13469-fig-0002-m.jpg)
Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -
![Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 - Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -](https://onlinelibrary.wiley.com/cms/asset/0aa40934-60e9-4ed0-bb9f-95f3f098bbe5/bjd13469-fig-0006-m.jpg)
Long‐term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate‐to‐severe psoriasis: results from the PHOENIX 2 study through 5 years of follow‐up - Langley - 2015 -
![Ο Άγιος Ιωάννης ο Πρόδρομος. Εικόνα στον Άγιο Νικόλαο. (1815). Έργο του Σπύρου Βεντούρα. | Painting, Art Ο Άγιος Ιωάννης ο Πρόδρομος. Εικόνα στον Άγιο Νικόλαο. (1815). Έργο του Σπύρου Βεντούρα. | Painting, Art](https://i.pinimg.com/736x/f4/fd/10/f4fd10640022a4855e65d7eb853a3267.jpg)